The Mayo Clinic Biobank: a building block for individualized medicine.
The Mayo Clinic Biobank: a building block for individualized medicine.
复制标题
DOI:
10.1016/j.mayocp.2013.06.006
复制
发表时间:
2013-09
影响因子:
8.9
通讯作者:
Cerhan JR
中科院分区:
文献类型:
--
作者:
Olson JE;Ryu E;Johnson KJ;Koenig BA;Maschke KJ;Morrisette JA;Liebow M;Takahashi PY;Fredericksen ZS;Sharma RG;Anderson KS;Hathcock MA;Carnahan JA;Pathak J;Lindor NM;Beebe TJ;Thibodeau SN;Cerhan JR
To report the design and first three years of enrollment of the Mayo Clinic Biobank. Preparations for this Biobank began with a 4-day Deliberative Community Engagement with local residents to obtain community input into the design and governance of the biobank. Recruitment, which began in April 2009, is ongoing with a target goal of 50,000. Any Mayo Clinic patient who is 18+ years, able to consent, and a US resident is eligible to participate. Each participant completes a health history questionnaire, provides a blood sample and allows access to existing tissue specimens and all data from their Mayo Clinic medical record (EMR). A Community Advisory Board provides ongoing advice and guidance on complex decisions. After three years of recruitment, 21,736 subjects have enrolled. Participants were 58% female, 95% of European ancestry, and median age of 62 years. Seventy-four percent lived in Minnesota, 42% from Olmsted County where the Mayo Clinic Rochester is located. The five most commonly self-reported conditions were hyperlipidemia (41%), hypertension (38%), osteoarthritis (30%), any cancer (29%), and gastroesophageal reflux disease (26%). Among self-reported cancer patients, the five most common types were non-melanoma skin cancer (14%), prostate cancer (12% in men), breast cancer (4%), melanoma (3%), and cervical cancer (2% in women). Fifty-six percent of participants had at least 15 years of EMR history. To date, over sixty projects and over 69,000 samples have been approved for use. The Mayo Clinic Biobank has quickly been established as a valuable resource for researchers.
登录
查看更多内容
DOI:
10.1016/0277-5379(83)90096-2
发表时间:
1983-01-01
期刊:
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY
影响因子:
--
作者:
COATES, A;DILLENBECK, CF;TATTERSALL, MHN
通讯作者:
TATTERSALL, MHN
影响因子:
5.1
作者:
Li, Chaoyang;Balluz, Lina S.;Pierannunzi, Carol
通讯作者:
Pierannunzi, Carol
影响因子:
12.7
作者:
Nelson, DE;Powell-Griner, E;Kovar, MG
通讯作者:
Kovar, MG
影响因子:
2.3
作者:
McCarty, Catherine A;Wilke, Russell A;Caldwell, Michael D
通讯作者:
Caldwell, Michael D
影响因子:
5.4
作者:
Secko, David M.;Preto, Nina;Burgess, Michael M.
通讯作者:
Burgess, Michael M.